These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9536937
21. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Annibale B, D'Ambra G, Luzzi I, Marcheggiano A, Iannoni C, Paoletti M, Anania MC, Marignani M, Delle Fave G. Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186 [Abstract] [Full Text] [Related]
22. Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients. Tari A, Hamada M, Kamiyasu T, Sumii K, Haruma K, Inoue M, Kishimoto S, Kajiyama G, Walsh JH. Dig Dis Sci; 1997 Aug; 42(8):1741-6. PubMed ID: 9286243 [Abstract] [Full Text] [Related]
23. Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. Khan Z, Nair P, O'Shea C, Spiers N, Playford RJ, Wicks AC. Scand J Gastroenterol; 2002 Feb; 37(2):144-7. PubMed ID: 11843048 [Abstract] [Full Text] [Related]
24. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Stack WA, Knifton A, Thirlwell D, Cockayne A, Jenkins D, Hawkey CJ, Atherton JC. Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054 [Abstract] [Full Text] [Related]
25. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A. Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566 [Abstract] [Full Text] [Related]
26. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A. Med Clin (Barc); 1998 Jan 17; 110(1):1-5. PubMed ID: 9527978 [Abstract] [Full Text] [Related]
27. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T. N Engl J Med; 1998 Dec 24; 339(26):1869-74. PubMed ID: 9862941 [Abstract] [Full Text] [Related]
28. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer. Hu FL, Jia JC, Li YL, Yang GB. J Int Med Res; 2003 Dec 24; 31(6):469-74. PubMed ID: 14708410 [Abstract] [Full Text] [Related]
29. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach. Namiot DB, Namiot Z, Kemona A, Bucki R, Gotebiewska M. Helicobacter; 2007 Feb 24; 12(1):63-7. PubMed ID: 17241303 [Abstract] [Full Text] [Related]
30. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion. Rune S. Digestion; 1992 Feb 24; 51 Suppl 1():11-6. PubMed ID: 1397740 [Abstract] [Full Text] [Related]
31. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Gastroenterology; 1995 Sep 24; 109(3):681-91. PubMed ID: 7657096 [Abstract] [Full Text] [Related]
33. Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. McColl KE, Nujumi AM, Dorrian CA, Macdonald AM, Fullarton GM, Harwood J. Scand J Gastroenterol; 1992 Sep 24; 27(2):93-8. PubMed ID: 1532864 [Abstract] [Full Text] [Related]
34. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. Yang JC, Wang HL, Chern HD, Shun CT, Lin BR, Lin CJ, Wang TH. Pharmacotherapy; 2011 Mar 24; 31(3):227-38. PubMed ID: 21361732 [Abstract] [Full Text] [Related]
37. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population. Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H. Helicobacter; 2005 Oct 24; 10(5):379-84. PubMed ID: 16181347 [Abstract] [Full Text] [Related]
38. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study). Koizumi W, Tanabe S, Nakatani K, Ishido K, Nishimura K, Azuma M, Ae T, Sasaki T, Higuchi K, Katada C, Nakayama N, Saigenji K. J Clin Pharm Ther; 2010 Jun 24; 35(3):303-7. PubMed ID: 20831531 [Abstract] [Full Text] [Related]
39. Therapeutic options after failed Helicobacter pylori eradication therapy. van der Hulst RW, Weel JF, van der Ende A, ten Kate FJ, Dankert J, Tytgat GN. Am J Gastroenterol; 1996 Nov 24; 91(11):2333-7. PubMed ID: 8931413 [Abstract] [Full Text] [Related]
40. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS. Hepatogastroenterology; 2007 Jun 24; 54(76):1293-6. PubMed ID: 17629092 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]